Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial
European Journal of Cancer · 2025-11 · 230 · 115808
DOI: 10.1016/j.ejca.2025.115808 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift European Journal of Cancer, 2025-11. Verfasst von Chunmei Bai und 38 weiteren Autor:innen. Beteiligte Einrichtung: Peking Union Medical College Hospital, Beijing, China. Hauptthemen laut MEDLINE: Esophagogastric Junction, Claudins, Stomach Neoplasms, Immunoconjugates. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Peking Union Medical College Hospital, Beijing, China.
- The First Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
- First Affiliated Hospital of Shandong First Medical University, Jinan, China.
- Zhejiang Cancer Hospital, Hangzhou, China.
- Zhongnan Hospital of Wuhan University, Wuhan, China.
- Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
Zitieren
APA
Bai, C., Zheng, Y., Sun, M., Ying, J., Zhou, F., Yu, Y., Xing, L., Zhang, Y., Wen, J., Wu, H., Yang, X., Wan, L., Guo, S., Zhao, R., Zhu, Z., Shen, W., Wang, Q., Gu, S., Wu, H., …, & Li, J. (2025). Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial. European Journal of Cancer, 230, 115808. https://doi.org/10.1016/j.ejca.2025.115808
Vancouver
Bai C, Zheng Y, Sun M, Ying J, Zhou F, Yu Y, et al. Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial. European Journal of Cancer. 2025;230:115808. doi:10.1016/j.ejca.2025.115808
BibTeX
@article{Bai2025,
author = {Bai, Chunmei and Zheng, Yi and Sun, Meili and Ying, Jieer and Zhou, Fuxiang and Yu, Yiyi and Xing, Ligang and Zhang, Yanqiao and Wen, Jinhua and Wu, Heshui and Yang, Xiuli and Wan, Lixin and Guo, Shiwei and Zhao, Rusen and Zhu, Zhizhen and Shen, Wei and Wang, Qi and Gu, Shanzhi and Wu, Hao and Chen, Weichang and Xia, Jin and Zhao, Jun and Dong, Xiaofang and Lou, Wenhui and Jiang, Kuirong and Zhang, Zhiye and Chen, Xiaobing and Fu, Deliang and Chen, Youshan and Wang, Baoqing and Liu, Jiaxin and Ji, Yuan and Yuan, Shijie and Li, Yuan and Gong, Zhihua and Fei, Da and Qin, Xia and Qin, Crystal and Li, Jin},
title = {Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial},
journal = {European Journal of Cancer},
year = {2025},
volume = {230},
pages = {115808},
doi = {10.1016/j.ejca.2025.115808}
}
EUVIMED